CIK: 0001388551 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $24,163 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XERS | XERIS BIOPHARMA HOLDINGS INC | 5,113,348 | $14,573 | 60.3% | $2.16 | +18.9% | COM | 98422E103 |
| RZLT | REZOLUTE INC | 1,318,967 | $6,397 | 26.5% | $9.52 | -51.8% | COM NEW | 76200L309 |
| SPY | SPDR S&P 500 ETF TR | 2,867 | $1,645 | 6.8% | $518.47 | — | TR UNIT | 78462F103 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,151 | $530 | 2.2% | $360.98 | +22.5% | CL B NEW | 084670702 |
| BCAX | BICARA THERAPEUTICS INC | 10,941 | $279 | 1.2% | $25.50 | 0.0% | COM | 055477103 |
| — | MIND MEDICINE MINDMED INC | 34,073 | $194 | 0.8% | $8.91 | — | COM NEW | 60255C885 |
| LXEO | LEXEO THERAPEUTICS INC | 17,851 | $161 | 0.7% | $13.31 | -10.4% | COM | 52886X107 |
| ABVX | ABIVAX SA | 11,365 | $131 | 0.5% | $10.70 | — | SPONSORED ADS | 00370M103 |
| KYTX | KYVERNA THERAPEUTICS INC | 22,981 | $112 | 0.5% | $23.94 | -67.8% | COM | 501976104 |
| CMPX | COMPASS THERAPEUTICS INC | 43,465 | $80 | 0.3% | $3.23 | -61.4% | COM | 20454B104 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $36 | 0.1% | $1.72 | +28.7% | COM | 21077P108 |
| — | ADICET BIO INC | 17,488 | $25 | 0.1% | $2.35 | — | COM | 007002108 |